Sponsor: Rubicon Genomics
Recording Date: 2/19/2014
Recording Time: 1 hour
Position Code: 13-PD-094,095
Reports To: Director, Research
As a member of the Research group, the Molecular Biologist will play a key role in developing the next generation of processes for the high throughput analysis of genomic DNA. The individual’s main responsibilities will be to help prepare and improve sequencing libraries. The successful candidate should have a keen desire to work at the bench.
• At least 5 years of experience in molecular biology
• Extensive experience with standard molecular biology enzymatic reactions, PCR, DNA cloning, genomic or cDNA library preparation, and sequencing
• Ability to independently design and execute experiments as well as work in a team environment
• Ability to analyze and coherently export results
• Excellent analytical and organizational skills, with great attention to detail and record keeping in both lab notebook and electronic documentation
• Experience in operating high-end analytical instrumentation
• Experience working with large datasets a plus
Complete Genomics does not accept unsolicited agency resumes. Please do not forward unsolicited agency resumes to our website, employees or Human Resources.
Complete Genomics will not pay fees to any third party agency or firm and will not be responsible for any agency fees associated with unsolicited resumes. Unsolicited resumes received will be considered property of Complete Genomics and will be processed accordingly without fee.
Complete Genomics has the sole discretion to determine with whom we will enter into a contract. If you wish to work with Complete Genomics, please contact the Human Resources department directly.
Complete Genomics is proud to be an equal opportunity employer
Apply on company website: http://tbe.taleo.net/CH03/ats/careers/jobSearch.jsp?org=COMPLETEGENOMICS...
Complete Genomics was formed in 2005 by Dr. Clifford A. Reid and Dr. Radoje T. Drmanac, who shared a vision to provide academic and biopharmaceutical researchers with whole human genomic data and analysis at an unprecedented quality, cost and scale without requiring researchers to invest in in-house sequencing instruments, high-performance computing resources and specialized personnel. Complete Genomics makes human genome sequencing, data analysis and management accessible for all scientific and medical researchers to conduct large-scale genomic research studies. It is through these studies that researchers understand the genetic basis of disease and gain insight into how we might prevent, diagnose and treat genetic diseases.
Complete Genomics was initially funded by various venture capital groups, eventually “going public” on the Nasdaq in 2010. In September 2012, the company announced that it had entered into an agreement to merge with BGI-Shenzhen, a privately-held company headquartered in Shenzhen, China and a recognized world leader in genome sequencing. That merger was completed in March 2013.